Novitzky Rejoins HISA Anti-Doping and Medication Control Committee

[Wandering Eyes]

Jeff Novitsky, currently the senior vice president, anti-doping compliance, for the Ultimate Fighting Championship (UFC), has been reappointed to the Anti-Doping and Medication Control (ADMC) Committee of the Horseracing Integrity and Safety Authority.

Prior to joining UFC in 2015, Novitsky was a federal agent with the U.S. Food and Drug Administration's Office of Criminal Investigations, leading investigations of companies suspected of illegally distributing performance-enhancing substances, including the case involving Lance Armstrong and the U.S. Postal Service Cycling Team.

Prior to that, Novitsky conducted Internal Revenue Service investigations into some of the highest-profile anti-doping cases in sports, including those involving the Bay Area Laboratory Co-Operative (BALCO) and Major League Baseball's Barry Bonds.

“Jeff's extensive expertise will be a tremendous asset to the ADMC Standing Committee,” said Charles Scheeler, Chair of the ADMC Standing Committee and the HISA Board of Directors. “His leadership in anti-doping enforcement and commitment to the principles of fair competition will further strengthen our mandate to promote transparency, safety and integrity in horse racing.”

HISA expressed its gratitude to Dr. Jerry Yon, who stepped down from the Committee on Dec. 31, 2024.

“We deeply appreciate Dr. Yon's invaluable contributions to the ADMC Standing Committee,” said Lisa Lazarus, CEO of HISA. “His dedication and insight have played a pivotal role in shaping the foundation of the ADMC Program, leaving a lasting legacy that will continue to strengthen the integrity and welfare of our sport.”

The full list of ADMC Standing Committee Members can be viewed here.

The post Novitzky Rejoins HISA Anti-Doping and Medication Control Committee appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

View the full article